West Nile-Innovator+EW

Manufacturer: Fort Dodge

Encephalomyelitis-west Nile Virus Vaccine

Eastern and Western, Killed Virus

West Nile-Innovator+EW Indications

For vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses. Efficacy of the West Nile fraction was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile Virus. The vaccine protected 95% of the vaccinates against infection, while 82% of the controls were viremic.

Dose

Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.

West Nile-Innovator+EW Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

U.S. Pat. No. 7,153,513 and patents pending

For Veterinary Use Only

© 2006 Fort Dodge Animal Health. All Rights Reserved.

Fort Dodge Animal Health, Fort Dodge, Iowa 50501 Usa

U.S. Vet. License No. 112

10 x 10 mL (10 Doses)

18093B

Nac No.

10032890